Croatia

 

AMEOS opens new medical campus in Germany

AMEOS Gruppe, Germany’s fourth largest hospital group by revenue, has opened a medical campus in Halberstadt, Saxony-Anhalt, to provide the clinical stage of medical degrees for 40 doctors a years, as part of a degree program which AMEOS has been running for the past three years in partnership with a Croatian university.
February 29, 2024

Croatian doctors threaten to strike, again

Relations between the healthcare workforce and the Croatian government appear to be souring. Having reached an agreement just nine months ago, the doctors' union is now complaining of ‘unfulfilled promises’, ‘propaganda attempts’ and ‘slave contracts.’ HBI asks, is more strike action likely to return?
February 2, 2024

HCA UK adopts Versius surgical robotic system in UK first

The rise of the robotic surgeon marches on. In a UK private sector first, hospital group HCA UK is adopting the Versius surgical robotic system. HBI speaks to an expert from UK-based consultancy Candesic to find out more.
February 2, 2024

New AI act could stifle EU innovation – but benefit the UK

After 38 hours of deliberation, a long-awaited deal has finally been reached in Brussels. HBI speaks to three market experts to understand what the AI Act - the comprehensive European framework for AI innovation and regulation - could mean for the future of healthcare in Europe.
December 15, 2023

HBI 2023: The outpatient differential

For years there has been a trend towards using outpatient services wherever possible - to improve patient outcomes, to better use an increasingly scarce workforce, and to increase cost efficiency. On the “Outpatient differential” panel at HBI 2023, how this push looks across the world was a key topic for discussion.
July 12, 2023

Orpea pledges to pay in full as restructuring rumours continue

French elderly care giant Orpea continues to hit the headlines for all the wrong reasons. Over the last week, dozens of facilities were raided by the French authorities, talk continues to be rife about restructuring and potential exits, and contrary to previous assertions HBI understands the group now intends to pay back the full €56m owed to the state.
November 25, 2022

Affidea deal – underbidders and EBITDA

HBI hears that the surprise buyer of European imaging and cancer treatment provider Affidea, Groupe Bruxelles Lambert (GBL) may not have been the highest bidder, despite winning out. HBI considers who else was in the running, and the EBITDA figure that may have been used for the deal.
April 28, 2022

Affidea bought by Groupe Bruxelles Lambert

Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.
April 19, 2022

Will record results for Synlab precipitate Cinven sale?

Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?
March 17, 2022

Affidea sale – potential price and buyers

European imaging and cancer treatment provider Affidea is for sale according to multiple sources. HBI chats to an operator source to find about more about the sale and to speculate on price and purchasers.
December 22, 2021
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us